EMA starts new benefit-risk assessment of flupirtine

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-017-38280-2
中图分类号
学科分类号
摘要
引用
收藏
页码:2 / 2
相关论文
共 50 条
  • [3] Regulatory benefit-risk assessment of oncology drugs: A systematic review of FDA and EMA approvals
    Pinto, Cathy Anne
    Balantac, Zaneta
    Mt-Isa, Shahrul
    Liu, Xinyue
    Bracco, Oswaldo L.
    Clarke, Harrison
    Tervonen, Tommi
    DRUG DISCOVERY TODAY, 2023, 28 (10)
  • [4] Regulatory benefit-risk assessment of oncology drugs: A systematic review of FDA and EMA approvals
    Tervonen, Tommi
    Pinto, Cathy Anne
    Dudek, Maria E.
    Mt-Isa, Shahrul
    Liu, Xinyue
    Bracco, Oswaldo
    Balantac, Zaneta
    Clarke, Harrison
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 135 - 135
  • [5] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Warner, Margaret R.
    Wolka, Anne M.
    Noel, Rebecca A.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (03) : 342 - 346
  • [6] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Margaret R. Warner
    Anne M. Wolka
    Rebecca A. Noel
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 342 - 346
  • [7] Benefit-risk assessment of vaccines
    Kochhar, Sonali
    Izurieta, Hector S.
    Chandler, Rebecca E.
    Hacker, Adam
    Chen, Robert T.
    Levitan, Bennett
    VACCINE, 2024, 42 (04) : 969 - 971
  • [8] Benefit-Risk Tradeoffs in Assessment of New Drugs and Devices
    Kaul, Sanjay
    Stockbridge, Norman
    Butler, Javed
    CIRCULATION, 2020, 142 (20) : 1974 - 1988
  • [9] Estimand in benefit-risk assessment
    Ren, Xinru
    Chen, X. Gregory
    Seifu, Yodit
    Wang, William
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2023, 33 (04) : 452 - 465
  • [10] BENEFIT-RISK ASSESSMENT TODAY
    HALL, RE
    JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1978, 55 (01) : 193 - 197